Clinical trial
Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation…
NCT00370045 · LifeBridge Health, Other · Unknown status
Key facts
| NCT number | NCT00370045 |
|---|---|
| Title | Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin |
| Official title | Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin -The CLEAR PLATELETS-2 Study |
| Lead sponsor | LifeBridge Health, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | Bivalirudin with and without eptifibatide |
| Enrollment | 200 |
| Start date | Mar 1, 2006 |
| First posted | Aug 30, 2006 |
| Last update posted | Aug 30, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: